BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 22, 2014
View Archived Issues
FGFR inhibitor active against cells harboring genetic mutations
Read More
Genetic loci associated with ovarian cancer prognosis
Read More
Novel miRNA biomarkers for predicting response to cardiac procedures
Read More
Researchers present further clinical data for Liproca depot
Read More
Cyclophilin inhibitor NVP-018 inhibits HBV preclinically
Read More
Scientists at Vitae Pharmaceuticals design new BACE1 inhibitors
Read More
Neuralstem gains permission to conduct chronic spinal cord injury trial
Read More
Preclinical in vivo transplantation of human stem-cell derived hepatocytes for liver cell therapy
Read More
Islet Sciences reports phase II data for remogliflozin etabonate
Read More
Kyowa Hakko Kirin and Amgen terminate agreement for mogamulizumab
Read More
Researchers in the U.S. disclose new tyrosine-protein kinase inhibitors
Read More
Adamed presents a novel bioconjugate for tumor-targeted drug delivery
Read More
Merck & Co. designs novel SYK inhibitors
Read More
French researchers patent new agents for tuberculosis and leprosy
Read More
French group synthesizes novel agents for cancer
Read More
Kissei launches Savene in Japan
Read More
NeuroVive Pharmaceutical reports on breakthrough in cellular energy regulation
Read More
Torii Pharmaceutical set to launch Riona in Japan for the treatment of hyperphosphatemia
Read More
Cyclenium and Southern Research Institute form drug discovery collaboration
Read More
Lilly's VEGF-inhibiting monoclonal antibody approved for gastric cancer
Read More
Volasertib granted orphan drug designation in the E.U. and U.S.
Read More
Ragwitek sublingual immunotherapy approved by FDA for hay fever
Read More
GSK-2586184 meets primary endpoint in psoriasis study
Read More
Akorn completes acquisition of Hi-Tech Pharmacal
Read More
Can-Fite and Smart Assays to develop A3AR biomarker test kit
Read More
FDA approves ofatumumab in untreated chronic lymphocytic leukemia
Read More